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ABSTRACT
Standard of care diagnostic procedure for suspected skin cancer is microscopic examination of
hematoxylin & eosin stained tissue by a pathologist. Areas of high inter-pathologist discordance
and rising biopsy rates necessitate higher efficiency and diagnostic reproducibility. We present and
validate a deep learning system which classifies digitized dermatopathology slides into 4 categories.
The system is developed using 5,070 images from a single lab, and tested on an uncurated set of
13,537 images from 3 test labs, using whole slide scanners manufactured by 3 different vendors.
The system’s use of deep-learning-based confidence scoring as a criterion to consider the result as
accurate yields an accuracy of up to 98%, and makes it adoptable in a real-world setting. Without
confidence scoring, the system achieved an accuracy of 78%. We anticipate that our deep learning
system will serve as a foundation enabling faster diagnosis of skin cancer, identification of cases for
specialist review, and targeted diagnostic classifications.
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1 INTRODUCTION
Every year in the United States, 12 million skin lesions are biopsied,1 with over 5 million new skin
cancer cases diagnosed.2 After a skin lesion is biopsied, the tissue is fixed, embedded, sectioned,
and stained with hematoxylin and eosin (H&E) on glass slides, ultimately to be examined under
microscope by a dermatologist, general pathologist or dermatopathologist who provides a diagnosis
for each tissue specimen. Owing to the large variety of over 500 distinct skin pathologies3 and the
severe consequences of a critical misdiagnosis,4 diagnosis in dermatopathology demands special-
ized training and education. Although the inter-observer concordance rate in dermatopathology is
estimated to be between 90 and 95%,5, 6 there are some distinctions which present frequent disagree-
ment among pathologists, such as in the case of melanoma vs. melanocytic nevi.7–11 Any system
which could improve diagnostic accuracy provides obvious benefits for dermatopathology labs and
patients; however, there are substantial benefits also to improving the distribution of pathologists’
workloads.12–14 This can reduce diagnostic turnaround times in several scenarios. For example,
when skin biopsies are interpreted initially by a dermatologist or a general pathologist, prior to re-
ferral to a dermatopathologist, it can result in a delay of days, sometimes in critical cases. In another
common scenario, additional staining is required to identify characteristics of the tissue not cap-
tured by standard H&E staining. If those additional stains are not ordered early enough, there can be
further delays to diagnosis. An intelligent system to distribute pathology workloads could alleviate
some of these bottlenecks in lab workflows. The rise in adoption of digital pathology1, 15 provides
an opportunity for the use of deep learning-based methods for closing these gaps in diagnostic reli-
ability and efficiency.16, 17
In recent years, deep neural networks have proven capable of identifying diagnostically relevant
patterns in radiology and pathology.18–25 While deep learning applied to medical imaging-based
diagnostic applications has progressed beyond proof-of-concept,18, 20, 22–24 the translation of these
methods to digital pathology must overcome unique challenges. Among these is sheer image size; a
whole slide image (WSI) can contain several gigabytes of data and billions of pixels. Additionally,
non-standardized image appearance (variability in tissue preparation, staining, scanned appearance,
presence of artifacts) and a large number of pathologic abnormalities that can be observed present
unique barriers to development of deployable deep learning applications in pathology. For example,
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Tellez et al.26 demonstrate the strong impact that inter-site variance– with respect to stain and other
image properties– can have on deep learning models. Nonetheless, deep learning-based methods
have recently shown promise in a number of tasks in digital pathology, primarily for segmentation
models and networks which classify small patches within a WSI.19, 26–35 More recent methods have
performed direct WSI classification.21, 25, 36 However, many focus only on a single diagnostic class to
make binary classifications,19, 25, 31, 36 the utility of which breaks down in addressing subspecialties
for which there is more than one relevant pathology of interest. Additionally, many of these methods
have focused on curated datasets consisting of fewer than 5 pathologies with little diagnostic and
image variability.19, 21, 31, 36
The insufficiency of models developed and tested using small curated datasets such as
CAMELYON29 was effectively demonstrated by Campanella et. al.25 However, while this study
claimed to validate on data free of curation, the data presented featured limited capture of not only
biological variability (e.g. exclusion of commonly-occurring prostatic interaepithelial neoplasia and
atypical glandular morphologies) but also image variability originating from slide preparation and
scanning characteristics (e.g. exclusion of slides with pen markings, need for retrospective human
correction of select results, and poorer performance on externally-scanned images). In contrast
to deep learning systems exposed to contrived pathology problems and datasets, pathologists are
trained to recognize hundreds of morphological variants of diseases they are likely to encounter in
their careers and must adapt to variations in tissue preparation and staining protocols. In addition
to these variations, deep learning algorithms can also be sensitive to image artifacts. Some research
has attempted to account for these issues by detecting and pre-screening image artifacts, either by
automatically37–39 or manually removing slides with artifacts.19, 25, 31 Campanella et. al25 include
variability in allowed artifacts which others lack, but still selectively exclude images with ink mark-
ings, which have been shown to affect predictions of neural networks.40
A real-world deep learning pathology system must be demonstrably robust to these variations. It
must be tested on non-selected specimens, with no exclusions and no manual pre-screening of slides
input or post-screening of the system outputs. A comprehensive test set for robustly assessing system
performance should contain images:
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1. From multiple labs, with markedly varied stain and image appearance due to imaging using
different whole slide image scanner models and vendors, and variability in tissue prepara-
tion and staining protocols.
2. Wholly representative of a diagnostic workload in the subspecialty (i.e. not excluding
pathologic or morphologic variations which occur in a sampled time-period).
3. With a host of naturally-occurring and human-induced artifacts: scratches, tissue fixation
artifacts, air bubbles, dust and dirt, smudges, out-of-focus or blurred regions, scanner-
induced misregistrations, striping, pen ink or letters on slides, inked tissue margins, patch-
ing errors, noise, color/calibration/light variations, knife-edge artifacts, tissue folds, and
lack of tissue present.
4. With no visible pathology (in some instances), or with no conclusive diagnosis, covering
the breadth of cases occurring in diagnostic practice.
In this work, we present a pathology deep learning system (PDLS) which is capable of classifying
WSIs containing H&E-stained skin biopsies or excisions into diagnostically-relevant classes (Basa-
loid, Squamous, Melanocytic and Other). A key aspect of our system is that it returns a measure
of confidence in its assessment; this is necessary in such classifications because of the wide range
of variability in the images. A real-world system should not only return accurate predictions for
commonly occurring diagnostic entities and image appearances, but also flag the non-negligible re-
mainder of images whose unusual features lie outside the range allowing reliable model prediction.
The PDLS is developed using 5,070 WSIs from a single lab (”Reference Lab”), and independently
tested on a completely uncurated and unrefined set of 13,537 sequentially accessioned H&E-stained
images from 3 additional labs, each using a different scanner and different staining and preparation
protocol. No images were excluded. To our knowledge, this test set is the largest in pathology to
date. Our PDLS satisfies all the criteria listed above for real-world assessment, and is therefore to
our knowledge the first truly real-world-validated deep learning system in pathology.
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2 RESULTS
2.1 OVERVIEW AND EVALUATION OF PDLS
The proposed system, as illustrated in Fig. 1, takes as input a WSI and classifies it using a cascade
of three independently-trained convolutional neural networks (CNNs) as follows: The first (CNN-1)
adapts the image appearance to a common feature domain, accounting for variations in stain and
appearance; the second (CNN-2) identifies regions of interest (ROI) for processing by the final net-
work (CNN-3), which classifies the WSI into one of 4 classes defined broadly by their histologic
characteristics—Basaloid, Melanocytic, Squamous, and Other, as further described in Methods. Al-
though the classifier operates at the level of an individual WSI, some specimens are represented by
multiple WSIs, and therefore these predictions are aggregated to produce a single specimen-level
classification. The classifier is trained such that for each image a predicted class is returned along
with a confidence in the accuracy of the outcome. This allows discarding of predictions that are
determined by the PDLS as likely to be false.
Since there is a large amount of variation in both pathologic findings of skin lesions as well as scan-
ner or preparation-induced abnormalities, it is very important for the model to assess a confidence
score for each decision; thereby, likely-misclassified images can be flagged as such. We developed
a method of confidence scoring based on Gal et al.41 and set confidence thresholds a priori based
only on performance on the validation set of the Reference Lab, which is independent of the data for
which we report all measures of system performance (see Methods). Three confidence thresholds
were calculated and fixed based on the Reference Lab validation set such that discarding specimens
with lower scores achieved the following 3 levels of accuracy in the remainder: 90% (Level 1), 95%
(Level 2) and 98% (Level 3).
To achieve high classification accuracy in the presence of a wide range of variability in tissue ap-
pearance between labs, a unique calibration set (about 520 WSIs) was collected from each lab and
used to fine-tune the final classifier (CNN-3). Results are reported only on the test set, consisting of
13,537 WSIs from the 3 test labs which were not used in model training or development. The deep
learning system effectively classifies WSIs into the 4 classes with an overall accuracy of 78% before
thresholding on confidence score. Importantly, in specimens whose predictions exceeded the confi-
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Figure 1: The process of classifying a whole slide image (WSI) with the pathology deep learning
system is shown. The input WSI is first segmented and divided into tissue patches (Tissue Seg-
mentation, Tiling); those patches pass through CNN-1, which adapts their stain and appearance to
the target domain; they then pass through CNN-2 which identifies the regions of interest (patches)
required to pass to CNN-3, which performs a 4-way classification, and repeats this 30 times to yield
30 predictions, where each prediction Pi is a vector of dimension Nclasses=4; the max of the class-
wise mean of sigmoid output is the confidence score. If the confidence score surpasses a pre-defined
threshold, the corresponding class decision is assigned.
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dence threshold, the PDLS achieved an accuracy of 83%, 94%, and 98% for confidence levels 1, 2
and 3, respectively. Performance of the PDLS is characterized with receiver operating characteristic
(ROC) curves, shown for each of the 4 classes in Fig. 2a-d at each confidence level; as confidence
level increases, a larger percentage of images do not meet the threshold and are excluded from the
analysis, as indicated by the colorbar. At Levels 1, 2, and 3, the percentage of test specimens ex-
ceeding the confidence threshold was 83%, 46% and 20%, respectively. Area under the curve (AUC)
increased with increasing confidence level. Similar results are shown for Level 1 for each test lab
in Fig. 2f-i which compare AUC and percentage of specimens confidently classified between the 3
labs. Fig. 3 shows the mapping of ground truth class to the proportion correctly predicted as well as
proportions confused for each of the other classes or remaining unclassified (at Level 1) due to lack
of a confident prediction or absence of any ROI detected by CNN-2. Additionally, this figure shows
the most common ground-truth diagnoses in each of the 4 classes found in the test set.
2.2 REDUCTION OF INTER-SITE VARIANCE
To demonstrate that the image adaptation performed by CNN-1 effectively reduces inter-site varia-
tions, we used t-distributed stochastic neighbour embedding (t-SNE) to compare the feature space of
CNN-2 with and without first performing the image adaptation step. We show CNN-2’s embedded
feature space without first performing image adaptation in Fig. 4a; Fig. 4b then shows the embedded
feature space from CNN-2 when image adaptation is performed first. Inclusion of the image adapta-
tion step results in more overlapped distributions in feature space than those produced without using
image adaptation; this transformation into a common feature space allows the system to perform
high-quality classification regardless of staining technique or scanner used.
2.3 EFFECTIVE CLASS SEPARATION
Additionally, we used t-SNE to show class separation based on the internal feature representation
learned by the final classifier (CNN-3), as shown in Fig. 4c. Each point in these t-SNE plots rep-
resents a single specimen with color denoting its ground-truth class. Figs. 4d-f show the same
information when thresholding at each of the 3 confidence levels (1-3, respectively), indicating in
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Figure 2: Receiver operating characteristic (ROC) curves are shown by lab, class, and confidence
level for the test set of 13,537 images. ROC curves are shown for Basaloid (a,g), Melanocytic
(b,h), Squamous (c,i) and Other (d,f) classes, with percentage of specimens classified for each curve
represented by the color bar at right. The three curves in each of (a-d) represent the respective
thresholded confidence levels or no confidence threshold (”None”). The three curves in each of (f-i)
represent the three labs. (e) Validation set accuracy in the Reference Lab is plotted versus sigmoid
confidence score, with dashed lines corresponding to the sigmoid confidence thresholds set (and
fixed) at 90% (Level 1), 95% (Level 2), and 98% (Level 3).
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Figure 3: Sankey diagram depicting the mapping of ground truth classes to the top 5 most common
diagnostic entities in the test set in each class (left). Malignant melanoma was not in the top 5
but included here due to its clinical importance. Also shown is the proportion of images correctly
classified, along with the distribution of misclassifications and unclassified specimens (those for
which confidence score was below the threshold) at confidence Level 1 (right). The width of each
bar is proportional to the corresponding number of specimens found in the 3-lab test set.
gray the specimens left unclassified at each. The clustering shows strong class separation between
the 4 classes, with stronger separation and fewer specimens classified as confidence level increases.
2.4 TIMING PROFILE
It is important that execution time for any system intended to be implemented in a lab workflow be
low enough to not present a bottleneck to diagnosis. Therefore, the proposed system was designed
to be parallelizable across WSIs to enhance throughput and meet the efficiency demands of the real-
world system. On a single compute node (described in Methods), the median processing time per
WSI was 137 seconds, with overall throughput of 40 WSIs/hour. Fig. 5a shows the median time
consumed by each stage in the pipeline, and Fig. 5b shows box-plots of time at each stage, as well
as end-to-end execution time.
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Figure 4: Image feature vectors are shown in 2-dimensional t-distributed stochastic neighbor em-
bedded (t-SNE) plots. Top: Feature embeddings from CNN-2 are shown with a) no prior image
adaptation and b) when image adaptation (using CNN-1) is performed prior to performing region
of interest (ROI) extraction using CNN-2. Each point is an image patch within a whole slide image
(WSI), colored by lab. Bottom: Feature embeddings from CNN-3, where each point represents a
specimen and is colored according to ground-truth classification. All specimens are classified at
baseline (a), where (d-f) show increasing confidence thresholds (d=Level 1, e=Level 2, f=Level 3),
with specimens not meeting the threshold in gray
.
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Figure 5: PDLS compute time for whole slide images on the calibration sets from the 3 test labs.
(a) The median percentage of total computation time for each stage in PDLS is shown. (b) A boxplot
of the computation time in seconds required at each stage of the pipeline is shown on a logarithmic
scale, along with total end-to-end execution time for all images (dark brown, median 137s), and
excluding images for which no regions of interest are detected (light brown, median 142s).
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3 DISCUSSION
Our work demonstrates the ability of a multi-site generalizable PDLS to accurately classify the
majority of specimens in a routine dermatopathology lab workflow.
Developing a deep-learning-based classification which translates across image sets from multiple
labs is non-trivial.25, 26, 30 Without compensation for image variations, non-morphological differ-
ences between data from different labs are more prominent in the feature space than morphological
differences between the specimens ultimately belonging to the same diagnostic classification. This
is demonstrated in Fig. 4a, in which the image patches cluster according to the lab that prepared and
scanned the corresponding slide. When image adaptation is performed prior to computing image
features, the images do not strongly cluster by lab (Fig. 4b). In this study, we demonstrate that a
PDLS trained on a single Reference Lab can be effectively calibrated to 3 additional lab sites. Figs.
4c-f show strong class separation between 4 classes, and this class separation strengthens with in-
creasing confidence threshold. Intuitively, low-confidence images cluster at the intersection of the 4
classes. Strong class separation is reflected also in the ROC curves, which show high AUC across
classes and labs, as seen in Fig. 2. AUC increases with increased confidence level, demonstrating
the utility of confidence score thresholding as a tunable method for excluding poor model predic-
tions. Figs. 2d shows relatively worse performance in the Other class. In 4c it can be seen that
there is some overlap between the Squamous and Other classes in feature space; Fig. 3 also shows
some confusion between these two classes, but overall, demonstrates accurate classification of the
majority of specimens from each class.
The majority of previous deep learning systems in digital pathology have been validated only on a
single lab or scanner’s images,19, 21, 25 curated datasets that ignored a portion of lab volume within a
speciality,19, 25, 32 and tested on small and unrepresentative datasets,19, 21, 32, 35 excluded images with
artifacts19, 25, 31 or selectively reverse image ”ground truth” retrospectively for misclassifications25
and train patch- or segmentation-based models while using traditional computer vision or heuristics
to arrive at a whole slide prediction.19, 29, 31 These methods do not lend themselves to real-world
enabled deep learning systems that are capable of operating independent of the pathologist and
prior to pathologist review. These systems would require some human intervention before they can
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provide useful information about a slide, and therefore do not enable improvements in lab workflow
efficiencies.
In contrast, our PDLS is trained on all available slides– images with artifacts, slides without tissue
on them, slides with poor staining or tissue preparation, slides exhibiting rare pathology, and those
with very subtle evidence of pathology. All of this variability in the data necessitates that our PDLS
is capable of determining when it is not likely to make a well-informed prediction. This is accom-
plished with a confidence score, which can be thresholded to obtain better system performance as
shown in Fig. 2a-e. Correlation between system accuracy and confidence was established a priori
using only the Reference Lab validation set (Fig. 2e) to fix the 3 confidence thresholds. By fixing
thresholds a priori we establish that they are generalizable. Campanella et al.25 have attempted to
similarly set a classification threshold which yields optimal performance; however, they perform
this thresholding using the last layer output of a model, on the same test set in which they report it
yielding 100% sensitivity; therefore they do not demonstrate the generalizability of this tuned pa-
rameter. Secondly, as Gal et. al41 demonstrate, a model’s predictive probability (last layer output)
cannot be interpreted as a measure of confidence.
We report all performance measures (accuracy, AUC) at the level of a specimen, which may consist
of several slides, since diagnosis is not reported at the slide level in dermatopathology. We aggregate
all slide-level decisions to the specimen level as reported in Methods; this is particularly important
as not all slides within a specimen will exhibit pathology, and therefore an incorrect prediction can
be made if slide-level-reporting is performed. Similar systems 19, 25, 35, 36 have not attempted to solve
the problem of aggregating slide-decisions to the specimen level at which diagnosis is performed.
For the PDLS to operate before pathologist assessment, the entire pipeline must be able to run in
a time period that avoids delaying the presentation of a case to the pathologist. The compute time
profile shown in Fig. 5a-b demonstrates that the PDLS can classify a WSI in under 3 minutes
in the majority of cases, which is on the same order of the amount of time it takes for today’s
scanners to scan a single slide. There was considerable variation in this number due to a large
amount of variability in the size of the tissue. However, it is important to note that this process
can be infinitely parallelized across WSIs to enhance throughput. Additional optimization of this
process is possible and is the subject of future work. There are several limitations to the current
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PDLS which are shared by previous implementations of deep learning image classification in digital
pathology. First, when diagnosing a specimen, pathologists often have access to additional clinical
information about the case, whereas our PDLS uses only WSIs to make a prediction. Training the
PDLS with this additional clinical context as input would likely improve accuracy in some cases. A
second limitation is that all existing systems for pathology classification attempt to put restrictions
on the biology, namely that a WSI or a specimen can only represent a single diagnosis. Rarely (2-3%
of specimens), a specimen should be labelled with more than one class. We did not train the current
PDLS to handle this special case since the available sample of images with dual ground-truth class
is small; however, this will be a subject of future research.
While the current PDLS does not make diagnostic predictions, its classification has the potential
to increase diagnostic efficiency and consistency in several scenarios. For example, pathologists
might choose to prioritize certain classes, e.g. Melanocytic, that may contain more difficult cases,
requiring longer review time, additional levels ordered, or ancillary testing such as immunostains.
Similarly, a dermatologist who interprets biopsies could choose to only receive cases classified as
Basaloid, and avoid receiving many inflammatory cases or melanocytic lesions which might be sent
for referral. The tunability of the confidence threshold in the model as a near-final step in assigning a
classification has further implications for how this deep learning system might be utilized in practice.
For applications that depend on high-sensitivity classification (e.g. treating classification as a form
of quality assurance to assist in avoiding missed diagnosis of melanomas, which should exist in the
Melanocytic classification), a higher confidence threshold might be set. Similarly, for an application
that depends less on specificity (e.g. triage of cases to balance pathologists’ workloads) the desired
confidence threshold could be lower, thereby avoiding an overly-large set of unclassified specimens.
Finally, as hierarchical classification models have been shown to outperform flat classifiers,42 we
expect that the current PDLS serves as a basis for extension to diagnostic classification systems.
This would enable further prioritization of more critical cases, such as those presenting features of
melanoma.
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3.1 CONCLUSION
The techniques presented herein–namely deep learning of heterogeneously-composed classes, and
confidence-based prediction screening– are not limited to application in dermatopathology or even
pathology, but broadly demonstrate potentially effective strategies for translational application of
deep learning in medical imaging. The PDLS presented delivers accurate prediction, regardless of
scanner type or lab, and requires minimal calibration to achieve accurate results for a new lab. The
system is capable of assessing which of its decisions are viable based on a computed confidence
score, and thereby can filter out predictions that are unlikely to be correct. This confidence-based
strategy is broadly applicable for achieving the low error rates necessary for the practical use of
machine learning in challenging and nuanced domains of medical disciplines.
4 METHODS
4.1 DATA USED IN DEVELOPMENT
The proposed system was developed in its entirety using H&E-stained WSIs from Dermatopathol-
ogy Laboratory of Central States, which is referred to as the Reference Lab in this work. All
slides from this Reference Lab were scanned using the Leica Aperio AT2 Scanscope (Aperio, Le-
ica Biosystems, Vista, California). This dataset is made up of two subsets, the first (3,070 WSIs)
consisting of images representing commonly diagnosed dermatopathologic entities, and the second
(2,000 slides) consisting of all cases accessioned during a discrete period of time, representing the
typical distribution seen by the lab. This combined Reference Lab set of 5,070 WSIs was partitioned
randomly into training (70%), validation (15%), and testing (15%) sets, such that WSIs from any
given specimen were not split between sets.
4.2 TAXONOMY
The design of target classes in this study is heavily influenced by the prevalence of each class’s
constituent pathologies and the presence of visually- and histologically-similar class-representative
features. They capture, in roughly equal proportion, the majority of diagnostic entities seen in a
dermatopathology lab practice. Specifically, we perform classification of WSIs into four classes:
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Basaloid, Squamous, Melanocytic, and Others. These four classes are defined by the following
histological descriptions of their features:
1. Basaloid: Abnormal proliferations of basaloid-oval cells having scant cytoplasm and fo-
cal hyperchromasia of nuclei; cells in islands of variable size with round, broad-based
and angular morphologies; peripheral palisading of nuclei, peritumoral clefting, and a fi-
bromyxoid stroma.
2. Squamous: Squamoid epithelial proliferations ranging from a hyperplastic, papillomatous
and thickened spinous layer to focal and full thickness atypia of the spinous zone as well
as invasive strands of atypical epithelium extending into the dermis at various levels.
3. Melanocytic: Cells of melanocytic origin in the dermis, in symmetric, nested, and dif-
fuse aggregates and within the intraepidermal compartment as single cell melanocytes and
nests of melanocytes. Nests may be variable in size, irregularly spaced, and single cell
melanocytes may be solitary, confluent, hyperchromatic, pagetoid and with pagetoid spread
into the epidermis. Cellular atypia can range from none to striking anaplasia and may be in
situ or invasive.
4. Other: Morphologic and histologic patterns that include either the absence of a specific
abnormality or one of a wide variety of other neoplastic and inflammatory disorders which
are both epithelial and dermal in location and etiology, and which are confidently classified
as not belonging to Classes 1-3.
These four classes account for more than 200 diagnostic entities in our test set, and their mapping to
the most prevalent diagnostic entities in the test set is illustrated in Fig. 3.
4.3 SYSTEM DESIGN AND TRAINING
Our image processing pipeline for the PDLS is illustrated in Fig. 1. The PDLS takes as input a WSI,
segments out regions containing tissue, and divides these regions into a set of tiles, each of size 128
× 128 pixels. The process of assigning a label to a WSI using this set of tiles is comprised of three
stages: 1) Image Adaptation, 2) Region of Interest Extraction, and 3) WSI Classification.
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Since the PDLS is trained on only a single lab’s data, it is critical to perform image adaptation
to adapt images received from test labs to a domain in which the image features are interpretable
by the PDLS. Without adaptation, unaccounted-for variations in the images due to staining and
scanning protocols can critically affect the performance of CNNs.25, 26, 30 The PDLS performs image
adaptation using a CNN (referred to as CNN-1), which takes as input an image tile and outputs
an adapted tile of the same size and shape but with standardized image appearance. CNN-1 was
trained using 300,000 tiles from the Reference Lab and mimics the average image appearance from
the Reference Lab given an input tile.
Subsequently, ROI extraction is performed using a second CNN (referred to as CNN-2). This CNN
is trained using expert annotations by a dermatopathologist as the ground truth. It performs a seg-
mentation of regions exhibiting abnormal features indicative of pathology. The model takes input of
a single tile and outputs a segmentation map. Tiles are selected corresponding to the positive regions
of the segmentation map; the set of all identified tiles of interest, t from a WSI is passed on to the
final stage classifier.
The final WSI classification is then performed using a third CNN (CNN-3), which predicts a label,
l for the set of tiles t identified by CNN-2 where:
l ∈ {Basaloid, Squamous, Melanocytic, Others}. (1)
CNN-3 additionally outputs a confidence score for each WSI. In clinical practice, and in our dataset,
diagnostic labels are reported at the level of a specimen, which may be represented by one or several
WSIs. Therefore, the predictions of the PDLS are aggregated across WSIs to the specimen level;
this is accomplished by assigning to a given specimen the maximum-confidence prediction across
all WSIs representing that specimen.
4.4 CALIBRATION AND VALIDATION FOR ADDITIONAL SITES
To demonstrate its robustness to variations in scanners, staining, and image acquisition protocols, the
PDLS was tested on 13,537 WSIs collected from 3 dermatopathology labs, representing two leading
dermatopathology labs in top academic medical centers (Dermatopathology Center at Thomas Jef-
ferson University and the Department of Dermatology at University of Florida College of Medicine)
and a high volume national private dermatopathology laboratory (Cockerell Dermatopathology).We
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refer to these as test labs. Prior to the study, each lab sought study approval from the appropri-
ate Institutional Review Board and was exempted. Each lab performed scanner validation prior
to data collection, according to the guidelines of the College of American Pathologists.43 Each
test lab selected a date range within the past 4 years (based on slide availability) from which to
scan a sequentially accessioned set of approximately 5,000 slides. Each of the 3 test labs scanned
their slides using a different scanner vendor and model. Scanner models used were: Leica Ape-
rio AT2 Scanscope Console (Leica Biosystems, Vista, California), Hamamatsu Nanozoomer-XR
(Hamamatsu Photonics, Hamamatsu City, Shizuoka, Japan), and 3DHistech Pannoramic 250 Flash
III (3DHistech, Budapest, Hungary). All parameters and stages of the PDLS pipeline were held
fixed after development on the Reference Lab, with the exception of CNN-3, whose weights were
fine-tuned independently for each lab using a calibration set of approximately 520 WSIs. (We re-
fer to this process as calibration). The calibration set for each lab consisted of approximately 500
sequentially-accessioned WSIs (pre-dating the test set) supplemented by 20 additional WSIs from
melanoma specimens. Of these calibration images, 80% were used for fine-tuning, and 20% for lab-
specific validation of the fine-tuning and image adaptation procedures. Specimens from the same
patient were not split between fine-tuning, validation and test sets. After this calibration, all pa-
rameters were permanently held fixed, and the system was run only once on each lab’s test set of
approximately 4,500 WSIs (range 4451 to 4585)– 13,537 in total.
4.5 CONFIDENCE SCORING AND THRESHOLD COMPUTATION
Gal et al.41 propose a method to reliably measure the uncertainty of a decision made by a classifier.
We have adapted this method for confidence scoring of the decision made by PDLS. To determine
a confidence score for a WSI we perfom prediction on the same WSI repeatedly for (using CNN-3)
several times by omitting a random subset of neurons (here 70%) in CNN-3 from the prediction.
Each repetition results in a prediction made using a different subset of feature representations. Here,
we use T = 30 repetitions, where each repetition i yields a prediction Pi, a vector of sigmoid values
of length equal to the number of classes. Each element of Pi represents the binary probability, pi,c,
of the corresponding WSI belonging to class c. The confidence score s for a given WSI is then
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computed as follows:
s = max
c
(∑T
i=1 pi,c
T
)
(2)
The class associated with the highest confidence s is the predicted class for the WSI. Finally, the
specimen prediction is assigned as the maximum-confidence prediction of its constituent WSI pre-
dictions. If a specimen’s confidence score is below a certain threshold, then the prediction is con-
sidered unreliable and the specimen remains unclassified. Three threshold values for the confidence
score were selected for analysis; these were determined during the development phase, using only
the Reference lab’s data, because this confidence threshold is a parameter which can tune model
performance. Confidence thresholds were selected such that discarding specimens with sigmoid
confidence lower than the threshold yielded a pre-defined level of accuracy in the remaining spec-
imens of the validation set of the Reference Lab. The three target accuracy levels were 90%, 95%
and 98%; the corresponding sigmoid confidence thresholds of 0.33, 0.76, and 0.99 correspond to
confidence Levels 1, 2, and 3 respectively; these confidence thresholds were held fixed, and applied
without modification to the test sets from the 3 test labs.
4.6 COMPUTE TIME
Compute time profiling of the PDLS was performed on an Amazon Web Services EC2 P3.8x large
instance equipped with 32 core Intel Xeon E5-2686 processors, 244 GB RAM, and four 16GB
NVIDIA Tesla v100 GPUs supported by NVLink for peer-to-peer GPU communication. Compute
time was measured on the calibration sets of each of the the test labs.
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